GLS and hepatocellular carcinoma: A chemical library screening of 13 compounds identified glutamine transporter inhibitor targeting alanine‐serine‐cysteine transporter, type‐2 (ASCT2, encoded by gene SLC1A5), V‐9302, showed the greatest synergism with GLS inhibitor, CB‐839, in suppressing HCC cells.